Disclosures for "Quantitation of Hypocretin Neuropeptides (Orexin-A and -B) in Human Cerebrospinal Fluid via HPLC with MS/MS Detection"
-
Dr. Pierce has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Pierce has stock in Takeda Pharmaceuticals.
-
Author has nothing to disclose
-
Mr. Palandra has nothing to disclose.
-
Dr. Hui has nothing to disclose.
-
Dr. Wu has nothing to disclose.
-
Mr. Wheeler has nothing to disclose.
-
Mr. Wiley has nothing to disclose.
-
Dr. Woolf has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Shah has nothing to disclose.
-
Dr. Yuan has received personal compensation for serving as an employee of PPD, part of Thermo Fisher Scientific.
-
Mr. Mylott has nothing to disclose.
-
Mr. Baratta has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mr. Baratta has stock in Takeda Pharmaceuticals. Mr. Baratta has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with FNIH.